207 related articles for article (PubMed ID: 38010007)
1. Acid-suppressive medication and incidence of chronic childhood immune-mediated diseases: A scoping review.
Madej J; Atanassova T; McGuire S; Cohen B; Weidner M; Zhang Y; Horton DB
Pediatr Allergy Immunol; 2023 Nov; 34(11):e14042. PubMed ID: 38010007
[TBL] [Abstract][Full Text] [Related]
2. Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children.
Noh Y; Jeong HE; Choi A; Choi EY; Pasternak B; Nordeng H; Bliddal M; Man KKC; Wong ICK; Yon DK; Shin JY
JAMA Pediatr; 2023 Mar; 177(3):267-277. PubMed ID: 36622684
[TBL] [Abstract][Full Text] [Related]
3. Association Between Use of Acid-Suppressive Medications and Antibiotics During Infancy and Allergic Diseases in Early Childhood.
Mitre E; Susi A; Kropp LE; Schwartz DJ; Gorman GH; Nylund CM
JAMA Pediatr; 2018 Jun; 172(6):e180315. PubMed ID: 29610864
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study.
Andersen AB; Erichsen R; Farkas DK; Mehnert F; Ehrenstein V; Sørensen HT
Aliment Pharmacol Ther; 2012 May; 35(10):1190-8. PubMed ID: 22443179
[TBL] [Abstract][Full Text] [Related]
5. Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study.
Mulder B; Schuiling-Veninga CC; Bos HJ; De Vries TW; Jick SS; Hak E
Clin Exp Allergy; 2014 Feb; 44(2):261-9. PubMed ID: 24164287
[TBL] [Abstract][Full Text] [Related]
6. Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H
Khawaja M; Thakker J; Kherallah R; Kitakaze M; Jneid H; Angiolillo DJ; Birnbaum Y
Cardiovasc Drugs Ther; 2024 Feb; 38(1):181-189. PubMed ID: 35715526
[TBL] [Abstract][Full Text] [Related]
7. Exposure to acid-suppressing drugs during pregnancy and the risk of asthma in childhood: an observational cohort study.
Cea Soriano L; Hernández-Díaz S; Johansson S; Nagy P; García-Rodríguez LA
Aliment Pharmacol Ther; 2016 Feb; 43(3):427-37. PubMed ID: 26612701
[TBL] [Abstract][Full Text] [Related]
8. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
9. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
[TBL] [Abstract][Full Text] [Related]
10. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
11. Acid suppressant medications and the risk of allergic diseases.
Robinson LB; Camargo CA
Expert Rev Clin Immunol; 2018 Sep; 14(9):771-780. PubMed ID: 30113236
[TBL] [Abstract][Full Text] [Related]
12. First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population-based register study.
Dehlink E; Yen E; Leichtner AM; Hait EJ; Fiebiger E
Clin Exp Allergy; 2009 Feb; 39(2):246-53. PubMed ID: 19134022
[TBL] [Abstract][Full Text] [Related]
13. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
[TBL] [Abstract][Full Text] [Related]
14. Risk of circulatory diseases associated with proton-pump inhibitors: a retrospective cohort study using electronic medical records in Thailand.
Pannoi T; Promchai C; Apiromruck P; Wongpraphairot S; Dong YH; Yang CC; Pan WC
PeerJ; 2024; 12():e16892. PubMed ID: 38371380
[TBL] [Abstract][Full Text] [Related]
15. Comparing safety of proton-pump inhibitors versus H2-receptor antagonists in kidney transplant recipients: A systematic review and meta-analysis.
Mohammadi K; Yaribash S; Razi B; Dashti-Khavidaki S
J Clin Pharm Ther; 2022 May; 47(5):567-574. PubMed ID: 34931328
[TBL] [Abstract][Full Text] [Related]
16. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
He N; Yan Y; Su S; Ge Q; Zhai S
Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
[TBL] [Abstract][Full Text] [Related]
17. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
[TBL] [Abstract][Full Text] [Related]
18. Association between acid-suppressive drug use and atopic dermatitis in patients with upper gastrointestinal diseases: A population-based retrospective cohort study.
Lin HC; Chen YY; Lin HL; Uang YS; Ho Y; Wang LH
J Clin Pharm Ther; 2021 Jun; 46(3):786-793. PubMed ID: 33403692
[TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring.
Yitshak-Sade M; Gorodischer R; Aviram M; Novack L
J Clin Pharmacol; 2016 Jan; 56(1):116-23. PubMed ID: 26096778
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.
Lam JR; Schneider JL; Zhao W; Corley DA
JAMA; 2013 Dec; 310(22):2435-42. PubMed ID: 24327038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]